5.56 (0.43%)
As of Feb 16, 2022
Source:
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a rapidly growing specialty pharmaceutical company working to deliver innovative therapies for individuals living with serious and debilitating chronic conditions. We have built a portfolio of products that includes utilizing our novel and proprietary BioErodible MucoAdhesive, or BEMA, drug-delivery technology to develop and commercialize new applications of proven therapies aimed at addressing important unmet medical needs.
| Country | United States |
| Headquarters | raleigh, north carolina |
| Phone Number | 919 582 9050 |
| Industry | manufacturing |
| CEO | /S/ Jeffrey Bailey |
| Website | bdsi.com |